NCT01086462View on ClinicalTrials.gov

Intravenous Microdose Pharmacokinetic (PK) Study With [14C]-GSK2239633

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 21, 2010

Primary Completion Date

February 22, 2010

Study Completion Date

February 22, 2010

Conditions
Asthma
Interventions
DRUG

GSK2239633

100 ug GSK2239633 containing approximately 10kBq \[14C\]-GSK2239633

Trial Locations (1)

9471 GP

GSK Investigational Site, Zuidlaren

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY